Valeritas has secured $150 million in a venture capital financing from Israeli and U.S. funds. The series C financing round was led by private equity firm Welsh, Carson, Anderson & Stowe with existing investors, including MPM Capital, HLM Venture Partners, CHL Medical Partners and Kaiser Permanente Ventures.
Israeli funds such as Pitango Venture Capital and Agate Medical Investments have also invested in the U.S. medical device company. The funding will finance the commercialization of its V-Go disposable insulin delivery device, which provides basal-bolus insulin therapy for adult diabetics.
Click here for the release from PR Newswire.